You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The program is intended to help make testing for the virus more accessible to New Yorkers, the partners said.
The Enzo and Access Bio tests may be performed by any CLIA-certified high complexity lab, while use of Gene By Gene's test is limited to its developer.
The company said clinical services revenues and diagnostic testing volumes fell during the quarter due to the negative impact of the COVID-19 pandemic.
LabCorp's test is being made available pursuant to FDA guidance that allows high-complexity, CLIA-certified labs to perform their own tests for SARS-CoV-2.
The company said clinical services revenues and diagnostic testing volumes rose during the quarter, but that PAMA continued to negatively affect reimbursements.
The GenFlex is a sample-to-result molecular diagnostic platform that includes sample collection, processing, amplification, and detection, the company said.
The firm also said it is contemplating selling its therapeutics division, and appointed David Bench as its new CFO.
The company said that the decline in revenues reflected lower industry-wide reimbursement rates under PAMA.
The assay is based on the company's AmpiProbe technology, which uses fluorescent reporter-labeled primers and quencher-labeled primers to amplify DNA.
The case, which was originally being fought between Enzo and Hologic, was decided in favor of Becton Dickinson, Hologic's co-plaintiff.
US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.
A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.
According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.
In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.